NCT00403962View on ClinicalTrials.gov

A Combination Therapy In Patients With Social Anxiety Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

August 31, 2005

Conditions
Social Phobia
Interventions
DRUG

vestipitant/paroxetine

Trial Locations (17)

1256

GSK Investigational Site, Koebenhavn K

1338

GSK Investigational Site, Sandvika

2100

GSK Investigational Site, Koebenhavn OE

2650

GSK Investigational Site, Hvidovre

3400

GSK Investigational Site, Hilleroed

4180

GSK Investigational Site, Soroe

7505

GSK Investigational Site, Tygerberg

8240

GSK Investigational Site, Risskov

8660

GSK Investigational Site, Skanderborg

10629

GSK Investigational Site, Berlin

13053

GSK Investigational Site, Berlin

28832

GSK Investigational Site, Achim

35625

GSK Investigational Site, Hüttenberg

N-5068

GSK Investigational Site, Bergen

N-2317

GSK Investigational Site, Hamar

0364

GSK Investigational Site, Oslo

Unknown

GSK Investigational Site, Bloemfontein

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY